Vanda Pharmaceuticals Reports Second Quarter 2026 Financial Results
Go back to Vanda Pharmaceuticals Reports Second Quarter 2026 Financial Results| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 5.38 -0.19 (3.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.57 | 52 Week High | $18.00 | |||
| Open | $5.52 | 52 Week Low | $6.91 | |||
| Day High | $5.52 | P/E | N/A | |||
| Day Low | $5.32 | EPS | $-0.67 | |||
| Volume | 915,774 | |||||

